Research articlePublished Sep 2013
Formulation and Development of In Situ Gelling System for Nasal Administration for Ondansetron Hydrochloride by Using Pluronic F-127
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the recent years one of the big problems with cancer chemotherapy is cancer induced nausea and vomiting (CINV). In the treatment of CINV the use of 5HT3 receptor antagonist is most popular. One of such 5HT3 antagonist is Ondansetron Hydrochloride. But Ondansetron has a low oral bioavailability along with a patient suffering from vomiting problem it is difficult to deliver the drug through oral route. So our objective is to prepare a in situ nasal gel of the Ondansetron using PF-127 as the thermoreversible polymer. We used HPMC E15 and Chitosan as the mucoadhesive polymer to increase the nasal residence time of the formulation. To increase the permeation we used Polyethylene Glycol 400 and Propylene glycol as the permeation enhancer.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalResearch & Reviews in Pharmacy and Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Anjan De”
- BylineArticles whose byline prints “Subrata Chakraborty”
- BylineArticles whose byline prints “Arup Mukherjee”
- BylineArticles whose byline prints “Jayanta Chattopadhyay”